Innovation Pharmaceuticals Inc (IPIX)

[FarmaZutical]

Kevetrin is the perfect candidate for BTD and I believe things can evolve very quickly if the later cohorts produce stage 4 patients with disappearing tumors. Ethically, it would be a crime to limit access to Kevetrin - especially for Stage 4 patient for whom no other options exist. With rolling review etc. I think Kevetrin could be partly approved within very few months / years.